Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
He<strong>al</strong>th Technology Assessment 1997; Vol. 1: No. 4Tsai MS, Chien TY, Yang YL, Chen HR, Hwang SM,1995. Identification of the number of the fragile-Xsyndrome CGG repeat using silver stain. Am J HumanGen<strong>et</strong>ics;57:1941.Tsong<strong>al</strong>is GJ, Silverman LM, 1993. Molecular pathologyof the fragile X syndrome [review]. Arch Path LabMed;117:1121–5.Turk J, 1992a. The fragile X syndrome: recentdevelopments. Curr Opin Psych;2:677–82.Turk J, 1992b. The fragile-X syndrome. On theway to a behaviour<strong>al</strong> phenotype [review].Br J Psych;160:24–35.Turk J, 1995a. <strong>Fragile</strong> X syndrome. Arch Dis Child;72:3–5.Turk J, 1995b. The psychiatric, psychologic<strong>al</strong> andbehaviour<strong>al</strong> functioning of a British sample of boyswith the fragile X syndrome [MD thesis]. Universityof London.Turk J, 1995c. Treatment of fragile-X syndrome.Arch Dis Child;72:544.Turner G,1996. Intelligence and the X chromosome.Lanc<strong>et</strong>;347:1814–15.Turner G, Turner B, 1974. X-linked ment<strong>al</strong> r<strong>et</strong>ardation.J Med Gen<strong>et</strong>ics;11:109–13.Turner G, Daniel A, Frost M, 1980. X-linked ment<strong>al</strong>r<strong>et</strong>ardation, macro-orchidism, and the Xq27 fragilesite. J Ped;96:837–41.Turner G, Robinson H, Laing S, Purvis-Smith S, 1986.Preventative screening <strong>for</strong> the fragile X syndrome.N Engl J Med;315:607–9.Turner G, Robinson H, Laing S, <strong>et</strong> <strong>al</strong>, 1992. Populationscreening <strong>for</strong> fragile X. Lanc<strong>et</strong>;339:1210–13.Turner AM, Robinson H, Wake S, Laing SJ, Leigh D,Turner G, 1994a. Counselling risk figures <strong>for</strong> fragileX carrier fem<strong>al</strong>es of varying band sizes <strong>for</strong> use inpredicting the likelihood of r<strong>et</strong>ardation in theiroffspring. Am J Med Gen<strong>et</strong>ics;51:458–62.Turner G, Robinson H, Wake S, Martin N, 1994b.Dizygous twinning and premature menopause infragile X syndrome. Lanc<strong>et</strong>;344:1500.Turner G, Webb T, Wake S, Robinson H, 1996.Prev<strong>al</strong>ence of fragile-x syndrome. Am J MedGen<strong>et</strong>ics;64:196–7.Väisänen ML, Kähkönen M, Leisti J, 1994. Diagnosisof fragile X syndrome by direct mutation an<strong>al</strong>ysis.Human Gen<strong>et</strong>ics;93:143–7.van den Ouweland AM, Deelen WH, Kunst CB, <strong>et</strong> <strong>al</strong>,1994a. Loss of mutation at the FMR1 locus throughmultiple exchanges b<strong>et</strong>ween matern<strong>al</strong> X chromosomes.Human Molec Gen<strong>et</strong>ics;3:1823–7.van den Ouweland AM, de Vries BB, Bakker PL, <strong>et</strong> <strong>al</strong>,1994b. DNA diagnosis of the fragile X syndrome in aseries of 236 ment<strong>al</strong>ly r<strong>et</strong>arded subjects and evidence<strong>for</strong> a revers<strong>al</strong> of mutation in the FMR-1 gene.Am J Med Gen<strong>et</strong>ics;51:482–5.Verheij C, Bakker CE, de Graaff E, <strong>et</strong> <strong>al</strong>, 1993.Characterization and loc<strong>al</strong>ization of the FMR-1gene product associated with fragile X syndrome.Nature;363:722–4.Verheij C, de Graaff E, Bakker CE, <strong>et</strong> <strong>al</strong>, 1995. Characterisationof FMR1 proteins isolated from different tissues.Human Molec Gen<strong>et</strong>ics;4:895–901.Verkerk AJ, Pier<strong>et</strong>ti M, Sutcliffe JS, <strong>et</strong> <strong>al</strong>, 1991. Identificationof a gene (FMR-1) containing a CGG repeatcoincident with a breakpoint cluster region exhibitinglength variation in fragile X syndrome. Cell;65:905–14.Verkerk AJMH, de Vries BBA, Niermeijer MF, <strong>et</strong> <strong>al</strong>,1992. Intragenic probe used <strong>for</strong> diagnostics in fragileX families. Am J Med Gen<strong>et</strong>ics;43:192–6.Vianna-Morgante AM, Otto PA. Notes on thepopulation gen<strong>et</strong>ics of fragile X syndrome.Am J Med Gen<strong>et</strong>ics;43:339–44.Vieregge P, Froster-Iskenius U, 1989. Clinico-neurologic<strong>al</strong>investigations in the fraX <strong>for</strong>m of ment<strong>al</strong> r<strong>et</strong>ardation.J Neurol;236:85–92.Vits L, De Boulle K, Reyniers E, <strong>et</strong> <strong>al</strong>, 1994. Apparentregression of the CGG repeat in FMR1 to an <strong>al</strong>lele ofnorm<strong>al</strong> size. Human Gen<strong>et</strong>ics;94:523–6.von Koskull H, Gahmberg N, S<strong>al</strong>onen R, S<strong>al</strong>o A,Peippo M, 1994. FRAXA locus in fragile X diagnosis:family studies, prenat<strong>al</strong> diagnosis, and diagnosis ofsporadic cases of ment<strong>al</strong> r<strong>et</strong>ardation. Am J MedGen<strong>et</strong>ics;51:486–9.Wake SA, Robinson H, 1995. Assessment of counselingof norm<strong>al</strong> m<strong>al</strong>es and norm<strong>al</strong> transmitting m<strong>al</strong>ecarriers identified in fragile-X families. Dev BrainDysfunction;8:319–26.Wang Q, Green E, Barnicoat A, <strong>et</strong> <strong>al</strong>, 1993. Cytogen<strong>et</strong>icversus DNA diagnosis in routine referr<strong>al</strong>s <strong>for</strong> fragile Xsyndrome. Lanc<strong>et</strong>;342:1025–6.Wang Q, Green E, Bobrow M, Mathew CG, 1995a.A rapid, non-radioactive screening test <strong>for</strong> fragileX mutations at the FRAXA and FRAXE loci. J MedGen<strong>et</strong>ics;32:170–3.Wang Q, Green E, Bobrow M, Mathew CG, 1995b.<strong>Screening</strong> <strong>for</strong> the fragile X A and E mutations byautomated fluorescent an<strong>al</strong>ysis. J Med Gen<strong>et</strong>ics;32:153.Watkiss E, Webb T, 1995. Comparison of m<strong>et</strong>hods<strong>for</strong> studying X inactivation status in fem<strong>al</strong>es. J MedGen<strong>et</strong>ics;32:151.Watson MS, Leckman JF, Annex B, <strong>et</strong> <strong>al</strong>, 1984. <strong>Fragile</strong>X in a survey of 75 autistic m<strong>al</strong>es [l<strong>et</strong>ter]. N Engl JMed;310:1462.Webb GC, Rogers JG, Pitt DB, H<strong>al</strong>liday J, Theob<strong>al</strong>d T,1981. Transmission of fragile (X) (q27) site from am<strong>al</strong>e [l<strong>et</strong>ter]. Lanc<strong>et</strong>;ii:1231–2.Webb J, 1993. A fragile case <strong>for</strong> screening.New Sci;140:10–11.67